Jitosacu 100 Tablet (14 Tab)

Jitosacu 100 Tablet Overview:

Jitosacu 100 Tablet is a cardiovascular medicine used to manage chronic heart failure in adults. It helps the heart pump blood more effectively, improves circulation, and reduces the risk of cardiovascular death and hospitalization due to long-term heart failure. It may also help lower high blood pressure, reducing strain on the heart and blood vessels.

Chronic heart failure occurs when the heart is unable to pump enough blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, reduced physical activity, and swelling of the feet, ankles, or legs due to fluid buildup.

Jitosacu 100 Tablet contains Sacubitril and Valsartan, an angiotensin receptor-neprilysin inhibitor (ARNI) combination. It works through a dual mechanism by enhancing the body's natural protective pathways that relax blood vessels and remove excess fluid, while blocking harmful hormones that increase blood pressure and overwork the heart. This helps improve heart function, relieve symptoms, and support better long-term cardiovascular health.

Composition:

Each film coated tablet contains- Sacubitril Sodium Eq. to Sacubitril: 49 mg, Valsartan: 51 mg and Excipients Q.S.

Colours: Ferric Oxide Yellow, Ferric Oxide Red & Titanium Dioxide.

Uses & Benefits of Jitosacu 100 Tablet:

Jitosacu 100 Tablet is primarily prescribed for the management of chronic heart failure and to reduce the risk of serious cardiovascular complications. Its key therapeutic uses include:

• Symptomatic Chronic Heart Failure (CHF)

Used in adults with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction to improve heart function and relieve symptoms such as breathlessness, fatigue, and fluid retention.

• Reduction of Cardiovascular Death and Hospitalization

Helps lower the risk of cardiovascular mortality and reduces the likelihood of hospitalization due to worsening heart failure.

How Does Jitosacu 100 Tablet Work:

Jitosacu 100 Tablet combines two active ingredients, Sacubitril (a neprilysin inhibitor) and Valsartan (an angiotensin receptor blocker, or ARB), which work synergistically as an ARNI to lower the strain on a weakened heart and protect the cardiovascular system through a dual pathway:

Sacubitril blocks the enzyme neprilysin, thereby preserving beneficial natural peptides in the body. This action promotes blood vessel dilation (vasodilation), signals the kidneys to excrete excess water and sodium in the urine, and protects the heart muscle from harmful scarring.

Valsartan blocks the action of Angiotensin II, a hormone that narrows blood vessels and raises blood pressure. By counteracting this hormone, it relaxes and dilates the pathways.

This dual action of Jitosacu 100 significantly improves blood circulation, decreases structural stress on the cardiovascular system, and makes it much easier for the heart to pump blood throughout the body.

Dosage of Jitosacu 100 Tablet:

• Usage Direction

Take Jitosacu 100 Tablet strictly according to your doctor’s instructions, following the prescribed dose and timing. Jitosacu 100 Tablet should be swallowed whole with water without breaking, chewing, or crushing it, preferably at the same time each day. Do not stop or alter the dose of Jitosacu 100 Tablet without consulting your doctor, as this may prevent you from achieving the desired outcome. If you are unsure about the administration procedures of Jitosacu 100, consult with your doctor or pharmacist.

• Missed Dose

If you miss a dose of Jitosacu 100 Tablet, take it as soon as you remember on the same day. But, if it is almost time for your next scheduled dose, skip the one you missed and continue following your regular dosing schedule. Do not attempt to take two doses if you have forgotten one. If you often forget to take your medication, consult with your doctor to re-evaluate your dosing schedule. Frequently missing doses could lead to undesired outcomes.

You can set reminders on your smartphone, keep drug organizer boxes, or use other audio-visual technologies to prevent missing a dose.

• Overdose

If you accidentally take Jitosacu 100 Tablet more than your prescribed dose, seek immediate medical attention or go to the nearest hospital for further advice. An overdose can cause a dangerous drop in blood pressure (severe hypotension), extreme dizziness, or fainting.

Contraindications of Jitosacu 100 Tablet:

Do not take Jitosacu 100 Tablet if you have a known hypersensitivity or allergy to Sacubitril, Valsartan, or any other ingredients present in this medicine.

It must not be used by patients with a history of angioedema, characterized by severe swelling of the face, lips, tongue, or throat, whether it was hereditary, idiopathic, or triggered by previous therapy with ACE inhibitors or ARBs. Furthermore, it is contraindicated for co-administration with Aliskiren in patients suffering from diabetes mellitus or moderate-to-severe kidney impairment.

Additionally, Jitosacu 100 Tablet must be avoided by patients with severe hepatic impairment, biliary cirrhosis, or cholestasis.

Precautions & Warnings of Jitosacu 100 Tablet:

Before starting Jitosacu 100 Tablet, it is essential to consult your healthcare provider and thoroughly discuss your complete medical history. This medication can cause symptomatic hypotension (a significant drop in blood pressure), particularly during the first few weeks of therapy, or if you are dehydrated, on a low-salt diet, or taking high-dose diuretics.

In addition, Jitosacu 100 can elevate potassium concentrations in the blood. Therefore, individuals with a tendency towards hyperkalemia need to have their potassium levels monitored periodically.

Furthermore, the medication may affect renal function. Regular blood tests to monitor serum creatinine and overall kidney health are essential throughout treatment, especially for patients with pre-existing renal impairment or renal artery stenosis.

Side Effects of Jitosacu 100 Tablet:

While taking Jitosacu 100 Tablet, you may experience side effects; however, most of them are mild and temporary as your body adjusts to the medication. Common side effects may include dizziness, fainting, cough, diarrhea, fatigue, tiredness, or weakness, and hypoglycaemia (low blood sugar), particularly in diabetic patients.

Conversely, serious side effects may also occur, requiring immediate medical advice. Symptoms like low blood pressure (hypotension), elevated blood potassium levels (hyperkalemia), and decreased kidney function frequently occur.

Seek emergency medical care immediately if you experience signs of angioedema, which include sudden swelling of the face, lips, tongue, throat, or limbs, or any difficulty breathing or swallowing.

Safety Related Concerns of Jitosacu 100 Tablet:

• Pregnancy

If pregnancy is detected, stop the medicine immediately and consult your doctor.

Label Warning: Fetal Toxicity

When pregnancy is detected, discontinue Valsartan as soon as possible. Drugs that can act directly on the renin-angiotensin system can cause injury and death to the developing fetus.

• Breastfeeding

It is unknown if the drug components pass into human breast milk. Due to the potential risk of adverse effects on nursing infants, Jitosacu 100 Tablet is not recommended while breastfeeding.

• Alcohol

Avoid alcohol consumption while taking Jitosacu 100 Tablet. Alcohol can worsen the blood pressure-lowering effects of the drug, leading to severe dizziness, drowsiness, or fainting.

• Food Interactions

There are no significant food interactions associated with Jitosacu 100 Tablet; it can be taken with or without food as advised by your doctor. However, avoid using potassium-containing salt substitutes or consuming excessive amounts of potassium-rich foods without consulting your physician, as this can severely elevate blood potassium levels.

Additionally, while maintaining a balanced, heart-healthy diet is highly recommended to support your treatment, individuals with known allergies to specific food items or dietary supplements should consult their healthcare professional before starting the medication to ensure a safe dietary plan.

• Drug Interactions

Jitosacu 100 Tablet can interact with a wide variety of medications, which can either compromise their effectiveness or increase the risk of toxicity. It is suggested to avoid taking this medication concurrently with ACE inhibitors, other angiotensin receptor blockers (ARBs), or aliskiren, as these combinations severely elevate the risk of life-threatening angioedema (deep tissue swelling) and profound hypotension.

Similarly, co-administration with potassium-sparing diuretics, potassium supplements, or potassium-retaining agents must be avoided, as it can lead to dangerous, life-threatening hyperkalemia (excessive blood potassium levels).

Furthermore, Jitosacu 100 can interact with a range of other commonly prescribed drugs, including statins, erectile dysfunction medications (such as sildenafil, tadalafil, vardenafil, or avanafil), nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2 inhibitors, lithium, furosemide, nitroglycerine, certain antibiotics, and metformin.

Always inform your healthcare provider and pharmacist about all medications you are taking, including prescription drugs, over-the-counter medications, vitamins, minerals, and herbal supplements, to avoid potential interactions.

• Using Machinery & Driving

Jitosacu 100 Tablet may cause dizziness, fainting, or fatigue. Avoid driving, operating heavy machinery, or performing any hazardous activities until you know how this medication affects you.

Storage of Jitosacu 100 Tablet:

Store below 30°C. Protect from light & moisture. Keep out of reach of children.

Avoid using it after the expiry date, printed on the packaging. Dispose of expired or unused medication properly; do not throw it away casually.

Additional Information:

• Follow a healthy, low-salt diet and limit fluids if advised by your doctor.
• Monitor your weight regularly and inform your doctor if you notice a sudden increase.
• Stay physically active with light exercises such as walking, as recommended by your healthcare provider.
• Avoid smoking and tobacco products, as they can worsen heart problems.
• Do not suddenly stop your medication unless your doctor specifically tells you to.
• Do not share your medicine with others, even if they have similar symptoms.

Frequently Asked Questions (FAQs):

Q. What is Jitosacu 100 Tablet used for?

A. Jitosacu 100 Tablet is used to manage chronic heart failure. It helps improve heart function, reduce hospitalization due to worsening heart failure, and support long-term cardiovascular health when prescribed by a physician

Q. Does Jitosacu 100 Tablet act as a blood thinner?

A. No, Jitosacu 100 Tablet is not a blood thinner. It is an Angiotensin Receptor-Neprilysin Inhibitor (ARNI) containing sacubitril and valsartan. It manages heart failure by relaxing blood vessels and removing excess fluid to reduce heart strain. It does not change the thickness or clotting ability of your blood.

Q. Can I stop taking Jitosacu 100 Tablet when my condition stabilizes or improves?

A. No, heart failure is a long-term condition. Discontinuing Jitosacu 100 abruptly can rapidly worsen your heart's pumping capability, leading to severe shortness of breath, sudden leg swelling, or emergency hospitalization. Always consult your physician before making any adjustments.

Q. Why do I feel dizzy when standing up quickly while taking Jitosacu Tablet?

A. This dizziness is a temporary drop in blood pressure referred to as orthostatic hypotension. Because Jitosacu 100 Tablet relaxes and widens your blood vessels to ease your heart's workload, your body needs a moment to adjust when you change positions. To manage this safely, transition very slowly from sitting or lying down to standing, and hold onto a stable surface until the feeling passes.

Q. Why do I need regular blood tests while taking Jitosacu 100 Tablet?

A. Your doctor will regularly order blood tests to verify that your kidneys are processing the medication safely and to check that your blood potassium levels have not risen to unsafe thresholds, which could alter your heart rhythm.

References:

1. ENTRESTO (sacubitril and valsartan) tablets. HIGHLIGHTS OF PRESCRIBING INFORMATION. Last Revised: February 2021. Accessed on: 22nd June 2026. Click Here

2. Entresto® film-coated tablets 50 mg/ 100 mg / 200 mg. NOVARTIS. Last Revised: November 2024. Accessed on: 22nd June 2026. Click Here

3. Patient Information. Sacubitril and Valsartan Tablets, for oral use. Last Revised: July 2024. Accessed on: 22nd June 2026. Click Here

4. ARNICOR Tablets. Sacubitril + Valsartan. Ciplamed. Last Revised: 24th July 2024. Accessed on: 22nd June 2026. Click Here